Two Sigma Investments
ZYNE

Two Sigma Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Two Sigma Investments’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-70,163
Closed -$22.9K – 3348
2023
Q2 		$22.9K Sell
70,163
-7
-0% -$3 ﹤0.01% 2895
2023
Q1 		$30.2K Sell
70,170
-900
-1% -$474 ﹤0.01% 2817
2022
Q4 		$37.7K Sell
71,070
-51,592
-42% -$32.7K ﹤0.01% 2621
2022
Q3 		$90K Buy
+122,662
New +$139K ﹤0.01% 2244
2022
Q2 		– Sell
-107,747
Closed -$221K – 3076
2022
Q1 		$221K Buy
107,747
+81,651
+313% +$194K ﹤0.01% 2315
2021
Q4 		$75K Sell
26,096
-164,334
-86% -$608K ﹤0.01% 4106
2021
Q3 		$807K Buy
190,430
+124,954
+191% +$557K ﹤0.01% 2814
2021
Q2 		$346K Buy
65,476
+1,730
+3% +$8.32K ﹤0.01% 3395
2021
Q1 		$296K Buy
+63,746
New +$289K ﹤0.01% 3336
2020
Q1 		– Sell
-69,563
Closed -$420K – 3994
2019
Q4 		$420K Buy
+69,563
New +$476K ﹤0.01% 2925
2019
Q1 		– Sell
-40,447
Closed -$120K – 3566
2018
Q4 		$120K Buy
+40,447
New +$221K ﹤0.01% 2791
2016
Q2 		– Sell
-14,851
Closed -$140K – 3323
2016
Q1 		$140K Buy
+14,851
New +$120K ﹤0.01% 2650

Other funds holding ZYNE

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments's ZYNE Position: Q3 2023 in Review

Two Sigma Investments sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2023, closing a stake of 70,163 shares — an estimated $22.9K sold.

Two Sigma Investments first reported a position in ZYNE in Q1 2016 and held it in 12 quarters. The position peaked at $807K in Q3 2021. 43 funds tracked by Wall St. Rank hold ZYNE as of Q3 2023.

  • Two Sigma Investments reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Investments sold 70,163 Zynerba Pharmaceuticals, Inc shares in Q3 2023, an estimated $22.9K.
  • Two Sigma Investments first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2016 and held it in 12 quarters.
  • Two Sigma Investments's Zynerba Pharmaceuticals, Inc position peaked at $807K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.